Research Parallel Session
Tracks
Room 3
| Tuesday, September 26, 2023 |
| 4:50 PM - 6:20 PM |
| Room 3 |
Details
Oral Presentations duration (each): 7 minutes + 1 minute Q&A
Speakers & Chairs
Prof Aki Laakso
Head Of R&D
HUS Helsinki University Hospital
Chair
Dr Katrin Rabiei
Consultant Neurosurgeon
Art Clinic
Chair
Prof Karl Schaller
Head Of Department
HUG - Neurochirurgie
Consciousness and the brain – a neurosurgical perspective
4:50 PM - 5:00 PM
Dr Valérie Schuermans
Resident Neurosurgery
MUMC+
Health Technology Assessment as a clinical research discipline
5:00 PM - 5:10 PM
Prof Andreas Raabe
Klinikdirektor und Chefarzt
Inselspital Universitätsklinik
New Technology in the OR - when is it implementation and when is it research?
5:10 PM - 5:20 PM
Prof Francesco Acerbi
Head, Neurovascular Revascularization Unit
Fondazione IRCCS Istituto Neurologico Carlo Besta
In vivo confocal endomicroscopy in neurosurgery: evaluation of accuracy in tumor tissue discrimination at tumor center and margins of resection from a prospective blinded trial
Dr David Bervini
Attending
Bern University Hospital, Inselspital
Intraoperative Laser Speckle Contrast Imaging To Assess Vessel Flow In Neurosurgery
Dr Nils Hecht
Neurosurgeon
Charité Berlin
Tissue partial pressure of oxygen during spreading depolarization in malignant stroke is associated with outcome
Mr Stefan Heene
Student
Heidelberg University
Systemic IL-4 application after tSCI elicits an anti-inflammatory response and improves functional outcome in rats.
Dr Tobias Rossmann
Attending
Kepler University Hospital
3D Exoscopes are Non-Inferior to Operating Microscopes in Aneurysm Surgery: Comparative Single-Surgeon Series of 52 Consecutive Cases
Dr Mindaugas Urbonas
Neurosurgeon
The Hospital of Lithuanian University of Health Sciences (LSMU) Kauno klinikos
The rs225014 Polymorphism in the DIO2 is Associated with Response to Ventriculoperitoneal Shunt in Patients with Idiopathic Normal Pressure Hydrocephalus
Dr Johannes Walter
Attending Physician
Universitätsklinikum Heidelberg
Systematic characterization of preclinical models of mild, moderate and severe TBI utilizing controlled cortical impact
